【レポートの概要（一部）】
1. Analyst View
2. Research Methodology
3. Global Cancer Drugs Market Outlook 2018
3.1 Cancer Incidences
3.2 Cancer Drug Market
4. Global Cancer Generics Market Analysis 2018
5. Cancer Generic Drugs Industry
5.1 Oral Generic Drugs
5.1.1 Arimidex (Anastrozole)
5.1.2 Femara (Letrozole)
5.1.3 Hycamtin (Topotecan)
5.1.4 Stivarga (Regorafenib)
5.1.5 Tarceva (Erlotinib)
5.1.6 Xalkori (Crizotinib)
5.1.7 Xeloda (Capecitabine)
5.2 Generic Injectables
5.2.1 Camptosar (Irinotecan Hydrochloride)
5.2.2 Eloxatin (Oxaliplatin)
5.2.3 Gemzar (Gemcitabine Hydrochloride)
5.2.4 Navelbine (Vinorelbine Tartrate)
5.2.5 Platinol (Cisplatin)
5.2.6 Taxol (Paclitaxel)
5.2.7 Taxotere (Docetaxel)
6. Cancer Generics Market: Major Indications
6.1 Lung Cancer
6.1.1 Incidence Outlook
6.1.2 Commercialized Drugs
6.2 Breast Cancer
6.2.1 Incidence Outlook
6.2.2 Commercialized Drugs
6.3 Colorectal Cancer
6.3.1 Incidence Outlook
6.3.2 Commercialized Drugs
6.4 Stomach Cancer
6.4.1 Incidence Outlook
6.4.2 Commercialized Drugs
6.5 Prostate Cancer
6.5.1 Incidence Outlook
6.5.2 Commercialized Drugs
7. Market Dynamics
7.1 Indian Generic Cancer Drug Introduced in the US Market
7.2 Launch of Generic Drugs for Oncology
7.3 Increasing Cancer Burden Paving Way for Generics
7.4 Patent Expiry of Blockbuster Oncology Drugs
7.5 Strategic Collaborations
8. Key Players
8.1 Fresenius Kabi AG
8.1.1 Business Overview
8.1.2 Key Financials
8.1.3 Strategic Developments
8.2 Actavis Plc.
8.2.1 Business Overview
8.2.2 Key Financials
8.2.3 Strategic Developments
8.3 Hospira
8.3.1 Business Overview
8.3.2 Key Financials
8.3.3 Strategic Developments
8.4 Teva Pharmaceutical Industries Ltd.
8.4.1 Business Overview
8.4.2 Key Financials
8.4.3 Strategic Developments
8.5 Mylan
8.5.1 Business Overview
8.5.2 Key Financials
8.5.3 Strategic Developments
8.6 Sun Pharmaceuticals
8.6.1 Business Overview
8.6.2 Key Financials
8.6.3 Strategic Developments
List of Figures:
Figure 3-1: Global – Number of New Cancer Cases (Million), 2012 & 2025
Figure 3-2: Global – Cancer Incidences by Gender (Million), 2012
Figure 3-3: Global – Cancer Drugs Market (Billion US$), 2008-2013
Figure 3-4: Global – Cancer Drugs Market (Billion US$), 2014-2018
Figure 3-5: Cancer Drugs Market Share by Geography (%), 2013
Figure 3-6: Cancer Drugs Market Share by Geography (%), 2018
Figure 3-7: Global – Cancer Treatment Modalities Revenue Share (%), 2013
Figure 4-1: Global – Cancer Generics Market (Billion US$), 2013-2018
Figure 6-1: Global – Number of New Lung Cancer Cases (Million), 2012 & 2020
Figure 6-2: Global – Forecast for New Lung Cancer Cases by Region (%), 2020
Figure 6-3: Global – Number of New Breast Cancer Cases (Million), 2012 & 2020
Figure 6-4: Global – Forecast for New Breast Cancer Cases by Region (%), 2020
Figure 6-5: Global – Number of New Colorectal Cancer Cases (Million), 2012 & 2020
Figure 6-6: Global – Forecast for New Colorectal Cancer Cases by Region (%), 2020
Figure 6-7: Global – Number of New Stomach Cancer Cases (Million), 2012 & 2020
Figure 6-8: Global – Forecast for New Stomach Cancer Cases by Region (%), 2020
Figure 6-9: Global – Number of New Prostate Cancer Cases (Million), 2012 & 2020
Figure 6-10: Global – Forecast for New Prostate Cancer Cases by Region (%), 2020
Figure 8-1: Fresenius Kabi – Sales & Net Income (Billion US$), 2012 & 2013
Figure 8-2: Fresenius Kabi – Revenue Share by Region (%), 2013
Figure 8-3: Fresenius Kabi – Revenue Share by Business Segment (%), 2013
Figure 8-4: Actavis – Sales & Net Income (Billion US$), 2012 & 2013
Figure 8-5: Actavis – Revenue Share by Region (%), 2013
Figure 8-6: Actavis – Revenue Share by Business Segment (%), 2013
Figure 8-7: Hospira – Sales & Net Income (Billion US$), 2012 & 2013
Figure 8-8: Hospira – Revenue Share by Region (%), 2013
Figure 8-9: Hospira – Revenue Share by Business Segment (%), 2013
Figure 8-10: Teva – Sales & Net Income (Billion US$), 2012 & 2013
Figure 8-11: Teva – Revenue Share by Region (%), 2013
Figure 8-12: Hospira – Revenue Share by Business Segment (%), 2013
Figure 8-13: Mylan – Sales & Net Income (Billion US$), 2012 & 2013
Figure 8-14: Mylan – Revenue Share by Region (%), 2013
Figure 8-15: Mylan – Revenue Share by Business Segment (%), 2013
Figure 8-16: Sun Pharma – Sales & Net Income (Billion US$), 2012-13/ 2013-14
Figure 8-17: Sun Pharma – Revenue Share by Business Segment (%), 2013-14
List of Tables:
Table 3-1: Most Prevalent Types of Cancer
Table 3-2: Top 10 Countries with Highest Cancer Prevalence Rates
Table 5-1: List of Companies Dealing in Generic Arimidex
Table 5-2: Cost Comparison of Generics and Branded Arimidex (Anastrozole)
Table 5-3: List of Companies Dealing in Generic Femara
Table 5-4: Cost Comparison of Generics and Branded Femara (Letrozole)
Table 5-5: List of Companies Dealing in Generic Hycamtin
Table 5-6: List of Companies Dealing in Generic Xeloda
Table 5-7: Cost Comparison of Generics and Branded Xeloda (Capecitabine)
Table 5-8: List of Companies Dealing in Generic Camptosar
Table 5-9: Cost Comparison of Generics and Branded Camptosar (Irinotecan Hydrochloride)
Table 5-10: List of Companies Dealing in Generic Gemzar (Gemcitabine Hydrochloride)
Table 5-11: Cost Comparison of Generics and Branded Gemzar (Gemcitabine Hydrochloride)
Table 5-12: List of Companies Dealing in Generic Navelbine (Vinorelbine)
Table 5-13: Cost Comparison of Generics and Branded Navelbine (Vinorelbine)
Table 5-14: List of Companies Dealing in Generic Platinol (Cisplatin)
Table 5-15: List of Companies Dealing in Generic Taxol (Paclitaxel)
Table 5-16: Cost Comparison of Generics and Branded Taxol (Paclitaxel)
Table 5-17: List of Companies Dealing in Generic Taxotere (Docetaxel)
Table 5-18: Cost Comparison of Generics and Branded Taxotere (Docetaxel)
Table 6-1: Top 10 Countries by Lung Cancer Incidences (2012)
Table 6-2: Global – Key Lung Cancer Drugs and Patent Expiry Status
Table 6-3: Top 10 Countries by Breast Cancer Incidences (2012)
Table 6-4: Global – Key Breast Cancer Drugs and Patent Expiry Status
Table 6-5: Top 10 Countries by Colorectal Cancer Incidences (2012)
Table 6-6: Global – Key Colorectal Cancer Drugs and Patent Expiry Status
Table 6-7: Top 10 Countries by Stomach Cancer Incidences (2012)
Table 6-8: Global – Key Stomach Cancer Drugs and Patent Expiry Status
Table 6-9: Top 10 Countries by Prostate Cancer Incidences (2012)
Table 6-10: Global – Key Prostate Cancer Drugs and Patent Expiry Status
Table 7-1: Global – Key Cancer Drugs and Patent Expiry Status
Table 8-1: Fresnius Kabi Pharmaceuticals – Key Cancer Generic Drugs
Table 8-2: Actavis – Key Cancer Generic Drugs
Table 8-3: Hospira – Key Cancer Generic Products
Table 8-4: Teva Pharmaceuticals – Key Cancer Generic Drugs
Table 8-5: Mylan – Key Cancer Generic Drugs
Table 8-6: Sun Pharmaceuticals – Key Cancer Generic Drugs
【レポート販売概要】
■ タイトル：世界の癌治療用ジェネリック医薬品市場■ 英文：Global Cancer Generics Market Outlook 2018
■ 発行日：2014年8月
■ 調査会社：RNCOS
■ 商品コード：RNCS4087
■ 調査対象地域：グローバル
- スマート照明（Smart Lighting）市場動向及び機会2013This report is NanoMarkets’ latest analysis of the worldwide smart lighting market. Revenues from smart lighting are expected to escalate rapidly in the coming decade, driven primarily by rising energy costs. However, NanoMarkets believes that the biggest wins in the smart lighting business will go to those who can differentiate themselves in the market by offering value-added features and interfa …
- 原子力発電動向2013Nuclear Power in 2013: Another Year of Resurgence Summary Rapid development in the field of nuclear energy is expected in 2013 as nations eagerly look towards building or restarting nuclear reactors. The industry, which witnessed a slowdown due to the Fukushima disaster, is expected to recover and develop quickly as several reactors are expected to come online or begin construction in 2013. In add …
- データセンター向けセキュリティソリューションの世界市場：論理的セキュリティ、物理的セキュリティThe global data center security market is estimated to grow at a CAGR of 11.4% from 2015 to 2020. Although the mature markets (such as the U.S. and the U.K.) hold larger shares in the data center security market, the Asia-Pacific region is expected to grow at the highest CAGR of 16.6% during the forecast period. The growth of the data center security market is driven by factors such as high usage …
- AR装置及びVR装置の世界市場2017-2021About Augmented Reality and Virtual Reality Gear AR is a technology that diminishes the line between reality and computer-generated graphics. It enhances a user's experience, in terms of what the user sees, hears, feels, and smells. VR creates an immersive computer-generated environment that is like the real word. VR technology uses computers to develop a simulated artificial environment. With VR, …
- 子宮内膜症(Endometriosis)の治療薬パイプライン動向（2015年上半期版）Endometriosis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Endometriosis - Pipeline Review, H1 2015’, provides an overview of the Endometriosis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Endometriosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA) …
- リスク分析の世界市場予測（～2024年）“Increasing level of complexity across business processes, and rising digitalization & business process automation is expected to drive the overall growth of risk analytics market”The risk analytics market size is expected to grow from USD 23.0 billion in 2019 to USD 45.9 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 14.8% during the forecast period. The risk analytics market is driv …
- 臨床試験の世界市場：フェーズ別（I/II/III/IV）、試験デザイン別（インターベンション、利用範囲拡大）、適応別（腫瘍、糖尿病、肥満）、セグメント予測The global clinical trials market size is expected to reach USD 68.9 billion by 2026, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 5.7% during the forecast period. Key drivers impacting the market growth are globalization of clinical trials, development of new treatments such as personalized medicine, augmenting evolution in technology, and rising d …
- 世界の接着剤及びシーラント市場動向（2012-2016）TechNavio's analysts forecast the Global Adhesives and Sealants market to grow at a CAGR of 3.86 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in R&D investment and activities. The Global Adhesives and Sealants market has also been witnessing an increasing demand from emerging markets. However, increasing price fluctuation of raw mater …
- 世界の電気・電子産業におけるCFD市場動向（2012-2016）TechNavio's analysts forecast the Global CFD market in the Electrical and Electronics Industry 2012-2016 to grow at a CAGR of 15.10 percent over the period 2012-2016. One of the key factors contributing to this market growth is the need to develop superior-quality products. The Global CFD market in the Electrical and Electronics industry has also been witnessing the increasing demand for integrate …
- 乾式構造の世界市場：種類、材料、システム、用途、地域別分析The demand for dry construction market has increased comprehensively in recent times; particularly because of increasing spending capacity, tremendous emphasis on the quality of products and services, and the inexpensive nature of the construction. Major dry construction associations are emphasizing on spreading awareness about dry construction, its lucrative side, and its cost-effectiveness. They …
- 世界の4Kテレビ市場（2014-2018）About 4K TV The Global Television market is all set to experience a shift from HD video to 4K technology. This innovation will upgrade the television viewing experience of consumers by providing them with video quality that is twice as good as HD and four times that of normal televisions. Large screen televisions in particular will show the pronounced benefits of 4K resolution. The use of 4K enabl …
- 建設ビジネスコンフィデンスレポート（Q1 2014）“Construction Business Confidence Report Q1 2014” is a new report by Timetric that analyzes construction industry executives’ views on the global economy, expectations for consumer confidence, supplier prices, key business concerns, and how executives’ future investments are set to change in Q1 2014. This report also provides access to a regional analysis of the industry’s outlook, industry and co …
- クラウドマイクロサービスの世界市場予測（～2023年）“The digital transformation is driving the global cloud microservices market.” The global cloud microservices market size is expected to grow from USD 683.2 million in 2018 to USD 1880.0 million by 2023, at a Compound Annual Growth Rate (CAGR) of 22.4% during the forecast period. Digital transformation, proliferation of microservices architecture, and customer-oriented businesses are some of the f …
- キッチンシンクの世界市場2019-2023About this market The APAC is expected to be the major contributor to the global residential building construction market led by rising urbanization and growing disposable income. As houses are considered a long-term asset. the people started investing on it to secure the future. In addition, house owners can rent the house as rent is a non-detectible expense. The growth in residential building co …
- ICT調達動向：教育産業部門 – 企業のICT投資計画Why was the report written? To highlight the criteria on which educational institutions select their ICT providers as well as the roles which have influence while making ICT purchasing decisions. What is the current market landscape and what is changing? Educational institutions are planning to increase their ICT spending in 2013 to improve their operational efficiency and increase student/staff s …
